Envestnet Portfolio Solutions Inc. lifted its stake in shares of MetLife, Inc. (NYSE:MET – Free Report) by 4.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 33,297 shares of the financial services provider’s stock after buying an additional 1,551 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in MetLife were worth $2,726,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also bought and sold shares of the company. CX Institutional grew its position in MetLife by 15.9% in the 4th quarter. CX Institutional now owns 68,005 shares of the financial services provider’s stock valued at $5,568,000 after purchasing an additional 9,337 shares during the period. Bank of New York Mellon Corp grew its position in MetLife by 109.2% in the 4th quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider’s stock valued at $722,727,000 after purchasing an additional 4,606,748 shares during the period. Smartleaf Asset Management LLC grew its position in MetLife by 27.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 13,692 shares of the financial services provider’s stock valued at $1,116,000 after purchasing an additional 2,940 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its position in MetLife by 1.7% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 776,244 shares of the financial services provider’s stock valued at $63,559,000 after purchasing an additional 12,723 shares during the period. Finally, B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in MetLife in the 3rd quarter valued at $2,960,000. Institutional investors and hedge funds own 94.99% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts recently issued reports on MET shares. JPMorgan Chase & Co. lifted their price target on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Barclays dropped their price objective on MetLife from $96.00 to $95.00 and set an “overweight” rating on the stock in a research note on Friday, February 7th. StockNews.com cut MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Morgan Stanley raised their price objective on MetLife from $101.00 to $109.00 and gave the company an “overweight” rating in a research note on Friday, February 28th. Finally, Keefe, Bruyette & Woods dropped their price objective on MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 12th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $94.58.
MetLife Trading Up 1.7 %
NYSE MET opened at $83.02 on Thursday. The stock has a market capitalization of $56.56 billion, a price-to-earnings ratio of 13.91, a PEG ratio of 0.65 and a beta of 1.04. MetLife, Inc. has a one year low of $67.30 and a one year high of $89.05. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. The business’s fifty day moving average is $83.44 and its 200-day moving average is $82.57.
MetLife (NYSE:MET – Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. Equities research analysts predict that MetLife, Inc. will post 9.65 EPS for the current year.
MetLife Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th were paid a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a yield of 2.63%. The ex-dividend date was Tuesday, February 4th. MetLife’s dividend payout ratio is currently 36.52%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- Pros And Cons Of Monthly Dividend Stocks
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- What Are Dividend Champions? How to Invest in the Champions
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Technology Stocks Explained: Here’s What to Know About Tech
- D-Wave and Quantum Supremacy: Implications For Investors
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.